Outcomes associated with hypogonadism in men with chronic kidney disease

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Chronic kidney disease is commonly accompanied by disturbances in the hypothalamic-pituitary-gonadal axis. Such disturbances in men give rise to hypogonadism and low circulating testosterone levels. The deficiency in testosterone can contribute to clinical outcomes such as sexual dysfunction, decreased bone mineralization, malnutrition and decreased muscle mass, and anemia. The administration of androgens to nonuremic hypogonadal men is usually effective in treating such outcomes. By contrast, the response to therapy in uremic men tends to be much less predictable. This variability in response is not surprising, because these same clinical outcomes can be the result of other aspects of the uremic state or the comorbid conditions that are frequently present in men with chronic kidney disease. Although further studies are needed, testosterone therapy may prove most useful as an adjunct to other more general therapies designed to address the uremic state.

Original languageEnglish (US)
Pages (from-to)342-347
Number of pages6
JournalAdvances in Chronic Kidney Disease
Issue number4
StatePublished - Oct 2004


  • Androgens
  • anemia
  • decreased bone mass
  • hypogonadism
  • malnutrition
  • sexual dysfunction

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'Outcomes associated with hypogonadism in men with chronic kidney disease'. Together they form a unique fingerprint.

Cite this